NCT05819918View on ClinicalTrials.gov

Calcifediol in the Treatment of COVID 19

CompletedOBSERVATIONAL
Enrollment

728

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

April 17, 2023

Study Completion Date

April 17, 2023

Conditions
COVID-19
Interventions
DRUG

Calcifediol

Subjects hospitalized with COVID-19 treated with calcifediol

DRUG

Best available therapy

Subjects hospitalized with COVID-19 treated with Azithromycin, hydroxychloroquine, corticoids and others authorized treatments.

Trial Locations (1)

14004

Hospital Universitario Reina Sofia, Córdoba

Sponsors
All Listed Sponsors
lead

Maimónides Biomedical Research Institute of Córdoba

OTHER